Swiss National Bank’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $987K | Sell |
121,296
-12,300
| -9% | -$100K | ﹤0.01% | 2151 |
|
2025
Q1 | $1.05M | Buy |
133,596
+35,300
| +36% | +$277K | ﹤0.01% | 2108 |
|
2024
Q4 | $1.46M | Hold |
98,296
| – | – | ﹤0.01% | 2032 |
|
2024
Q3 | $1.5M | Hold |
98,296
| – | – | ﹤0.01% | 2010 |
|
2024
Q2 | $1.5M | Buy |
98,296
+2,900
| +3% | +$44.2K | ﹤0.01% | 1958 |
|
2024
Q1 | $1.8M | Hold |
95,396
| – | – | ﹤0.01% | 1893 |
|
2023
Q4 | $1.82M | Sell |
95,396
-9,000
| -9% | -$172K | ﹤0.01% | 1900 |
|
2023
Q3 | $1.87M | Buy |
104,396
+9,100
| +10% | +$163K | ﹤0.01% | 1881 |
|
2023
Q2 | $1.94M | Buy |
95,296
+1,600
| +2% | +$32.5K | ﹤0.01% | 1913 |
|
2023
Q1 | $1.71M | Sell |
93,696
-10,800
| -10% | -$197K | ﹤0.01% | 1938 |
|
2022
Q4 | $2.16M | Buy |
104,496
+2,500
| +2% | +$51.7K | ﹤0.01% | 1850 |
|
2022
Q3 | $2.67M | Buy |
101,996
+1,500
| +1% | +$39.2K | ﹤0.01% | 1675 |
|
2022
Q2 | $2.55M | Buy |
100,496
+9,200
| +10% | +$233K | ﹤0.01% | 1749 |
|
2022
Q1 | $2.88M | Buy |
91,296
+4,800
| +6% | +$151K | ﹤0.01% | 1812 |
|
2021
Q4 | $3.5M | Buy |
86,496
+600
| +0.7% | +$24.3K | ﹤0.01% | 1698 |
|
2021
Q3 | $3M | Hold |
85,896
| – | – | ﹤0.01% | 1786 |
|
2021
Q2 | $2.36M | Sell |
85,896
-10,600
| -11% | -$291K | ﹤0.01% | 1999 |
|
2021
Q1 | $2.71M | Buy |
96,496
+1,100
| +1% | +$30.9K | ﹤0.01% | 1828 |
|
2020
Q4 | $2.48M | Buy |
95,396
+11,600
| +14% | +$301K | ﹤0.01% | 1787 |
|
2020
Q3 | $1.44M | Buy |
83,796
+1,300
| +2% | +$22.3K | ﹤0.01% | 1885 |
|
2020
Q2 | $2.04M | Buy |
82,496
+37,996
| +85% | +$940K | ﹤0.01% | 1702 |
|
2020
Q1 | $618K | Buy |
44,500
+1,300
| +3% | +$18.1K | ﹤0.01% | 2084 |
|
2019
Q4 | $436K | Hold |
43,200
| – | – | ﹤0.01% | 2449 |
|
2019
Q3 | $393K | Hold |
43,200
| – | – | ﹤0.01% | 2419 |
|
2019
Q2 | $343K | Hold |
43,200
| – | – | ﹤0.01% | 2496 |
|
2019
Q1 | $540K | Hold |
43,200
| – | – | ﹤0.01% | 2351 |
|
2018
Q4 | $465K | Buy |
+43,200
| New | +$465K | ﹤0.01% | 2378 |
|